29871907Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DLClinical cancer research : an official journal of the American Association for Cancer ResearchEquilibrative Nucleoside Transporter 1; HSP90 Heat-Shock Proteins; Hypertension; NeoplasmsAdult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Clinical Trials as Topic; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Human Umbilical Vein Endothelial Cells; Humans; Male; Middle Aged; Neovascularization, Pathologic; Vascular Endothelial Growth Factor AIdentification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res. 2018 10 01; 24(19):4734-4744.Clin Cancer Res2018-06-05T00:00:002018Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461294Aged, 80 and overD000368Living Beings1341183530.294764AgedD000328Living Beings1578255770.254432AdultD006973Disorders25811390.526672HypertensionAuthorship 118999190.1670970.1670971authors10.2519has subject areaD009389Disorders1303520.823558Neovascularization, PathologicD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617MaleMedicine-Hematology and OncologyD020533Chemicals & DrugsPhysiology1073090.812499Angiogenesis InhibitorsD033721Chemicals & Drugs220.998979Equilibrative Nucleoside Transporter 1D061307Anatomy42630.969734Human Umbilical Vein Endothelial CellsD018841Chemicals & Drugs35460.959842HSP90 Heat-Shock ProteinsD055106Procedures21716110.566048Genome-Wide Association StudyD042461Chemicals & Drugs1564070.844293Vascular Endothelial Growth Factor AD002986Procedures32811680.665227Clinical Trials as TopicD000068258732810.891431BevacizumabD009369Disorders55628890.33847NeoplasmsD020022Physiology39922670.521961Genetic Predisposition to DiseaseUniversity of ChicagoMark J.RatainMark J. Ratain41.78927490000000-87.601250000000001401Ratain, Mark J.Professortrue1ProfessorProfessor